Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Oasmia advances its next-generation XR-18 drug delivery technology

Jan. 24, 2022

Engineered virus-like particles for in vivo delivery of gene editing proteins

Jan. 24, 2022

Subcutaneous nanocarrier-mediated delivery of rapamycin

Jan. 19, 2022

4basebio and eTheRNA collaborate to evaluate linear DNA for mRNA production

Jan. 18, 2022

PostEra and Pfizer expand strategic collaboration

Jan. 12, 2022

Methamphetamine harnessed for good in BBB transport

Jan. 12, 2022

Amgen and Arrakis collaborate to discover and develop targeted RNA degrader therapeutics

Jan. 12, 2022

Pfizer and Codex DNA collaborate to leverage EDS technology for mRNA-based vaccines

Jan. 11, 2022

Pfizer and Beam Therapeutics collaborate to advance in vivo base editing programs

Jan. 10, 2022

Bayer and Mammoth Biosciences enter collaboration and option agreement on Mammoth's CRISPR systems

Jan. 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...